{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:05:39Z","timestamp":1790071539297,"version":"4.0.1"},"publisher-location":"New York, NY","reference-count":16,"publisher":"Springer US","isbn-type":[{"value":"9781071655467","type":"print"},{"value":"9781071655474","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2027]]},"DOI":"10.1007\/978-1-0716-5547-4_10","type":"book-chapter","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:25:23Z","timestamp":1790069123000},"page":"201-218","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lipid Nanoparticle-Mediated Delivery of CRISPR\u2013Cas9 Components for Genome Editing"],"prefix":"10.1007","author":[{"given":"Amalie Lykke","family":"Olsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla Blunk","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasmus Karred","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonglun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"issue":"12","key":"10_CR1","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou X, Zaks T, Langer R, Dong Y (2021) Lipid nanoparticles for mRNA delivery. Nat Rev Mater 6(12):1078\u20131094. https:\/\/doi.org\/10.1038\/s41578-021-00358-0","journal-title":"Nat Rev Mater"},{"key":"10_CR2","doi-asserted-by":"publisher","first-page":"124751","DOI":"10.1016\/j.jchromb.2025.124751","volume":"1265","author":"N Pavlin","year":"2025","unstructured":"Pavlin N et al (2025) Analysis of lipid nanoparticles using two-dimensional chromatography: simultaneous determination of encapsulation efficiency, nucleic acid integrity, and size of LNP formulations. J Chromatogr B 1265:124751. https:\/\/doi.org\/10.1016\/j.jchromb.2025.124751","journal-title":"J Chromatogr B"},{"key":"10_CR3","doi-asserted-by":"publisher","unstructured":"Makkar SK (2025) Advances in RNA-based therapeutics: current breakthroughs, clinical translation, and future perspectives. Front Genet 16. https:\/\/doi.org\/10.3389\/fgene.2025.1675209","DOI":"10.3389\/fgene.2025.1675209"},{"issue":"1","key":"10_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-02044-5","volume":"21","author":"C Wang","year":"2023","unstructured":"Wang C et al (2023) Emerging non-viral vectors for gene delivery. J Nanobiotechnol 21(1):272. https:\/\/doi.org\/10.1186\/s12951-023-02044-5","journal-title":"J Nanobiotechnol"},{"issue":"6","key":"10_CR5","doi-asserted-by":"publisher","first-page":"666","DOI":"10.3390\/vaccines12060666","volume":"12","author":"M Li","year":"2024","unstructured":"Li M et al (2024) Lipid nanoparticles outperform electroporation in delivering therapeutic HPV DNA vaccines. Vaccines 12(6):666","journal-title":"Vaccines"},{"issue":"6","key":"10_CR6","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa2107454","volume":"385","author":"JD Gillmore","year":"2021","unstructured":"Gillmore JD et al (2021) CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis. N Engl J Med 385(6):493\u2013502. https:\/\/doi.org\/10.1056\/NEJMoa2107454","journal-title":"N Engl J Med"},{"issue":"22","key":"10_CR7","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMoa2504747","volume":"392","author":"K Musunuru","year":"2025","unstructured":"Musunuru K et al (2025) Patient-specific in vivo gene editing to treat a rare genetic disease. N Engl J Med 392(22):2235\u20132243. https:\/\/doi.org\/10.1056\/NEJMoa2504747","journal-title":"N Engl J Med"},{"issue":"11","key":"10_CR8","doi-asserted-by":"publisher","first-page":"e2307800120","DOI":"10.1073\/pnas.2307800120","volume":"121","author":"S Chatterjee","year":"2024","unstructured":"Chatterjee S, Kon E, Sharma P, Peer D (2024) Endosomal escape: a bottleneck for LNP-mediated therapeutics. Proc Natl Acad Sci USA 121(11):e2307800120. https:\/\/doi.org\/10.1073\/pnas.2307800120","journal-title":"Proc Natl Acad Sci USA"},{"key":"10_CR9","doi-asserted-by":"publisher","unstructured":"Wang J et al (2024) Recent advances in lipid nanoparticles and their safety concerns for mRNA delivery. Vaccines (Basel) 12(10) https:\/\/doi.org\/10.3390\/vaccines12101148","DOI":"10.3390\/vaccines12101148"},{"issue":"1","key":"10_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60959-z","volume":"16","author":"JM Johansson","year":"2025","unstructured":"Johansson JM et al (2025) Cellular and biophysical barriers to lipid nanoparticle mediated delivery of RNA to the cytosol. Nat Commun 16(1):5354. https:\/\/doi.org\/10.1038\/s41467-025-60959-z","journal-title":"Nat Commun"},{"issue":"1","key":"10_CR11","doi-asserted-by":"publisher","first-page":"101436","DOI":"10.1016\/j.omtm.2025.101436","volume":"33","author":"M Hosseini-Kharat","year":"2025","unstructured":"Hosseini-Kharat M, Bremmell KE, Prestidge CA (2025) Why do lipid nanoparticles target the liver? Understanding of biodistribution and liver-specific tropism. Mol Ther Methods  Clin Dev 33(1):101436. https:\/\/doi.org\/10.1016\/j.omtm.2025.101436","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"1","key":"10_CR12","doi-asserted-by":"publisher","first-page":"e3642","DOI":"10.1002\/jgm.3642","volume":"26","author":"B Tafech","year":"2024","unstructured":"Tafech B, Mohabatpour F, Hedtrich S (2024) Surface modification of lipid nanoparticles for gene therapy. J Gene Med 26(1):e3642. https:\/\/doi.org\/10.1002\/jgm.3642","journal-title":"J Gene Med"},{"issue":"1","key":"10_CR13","doi-asserted-by":"publisher","first-page":"2200071","DOI":"10.1002\/smsc.202200071","volume":"3","author":"K Hashiba","year":"2023","unstructured":"Hashiba K et al. (2023) Branching ionizable lipids can enhance the stability, fusogenicity, and functional delivery of mRNA. Small Sci 3(1):2200071. https:\/\/doi.org\/10.1002\/smsc.202200071","journal-title":"Small Sci"},{"key":"10_CR14","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jconrel.2025.01.071","volume":"380","author":"L Zhang","year":"2025","unstructured":"Zhang L et al. (2025) Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines. J Control Release 380:108\u2013124. https:\/\/doi.org\/10.1016\/j.jconrel.2025.01.071","journal-title":"J Control Release"},{"issue":"4","key":"10_CR15","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","volume":"15","author":"Q Cheng","year":"2020","unstructured":"Cheng Q et al. (2020) Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013Cas gene editing. Nat Nanotechnol 15(4):313\u2013320. https:\/\/doi.org\/10.1038\/s41565-020-0669-6","journal-title":"Nat Nanotechnol"},{"issue":"13","key":"10_CR16","doi-asserted-by":"publisher","first-page":"2203033","DOI":"10.1002\/adhm.202203033","volume":"12","author":"H Seo","year":"2023","unstructured":"Seo H, Jeon L, Kwon J, Lee H (2023) High-precision synthesis of RNA-loaded lipid nanoparticles for biomedical applications. Adv Healthc Mater 12(13):2203033. https:\/\/doi.org\/10.1002\/adhm.202203033","journal-title":"Adv Healthc Mater"}],"container-title":["Methods in Molecular Biology","CRISPR Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5547-4_10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:25:23Z","timestamp":1790069123000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5547-4_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"ISBN":["9781071655467","9781071655474"],"references-count":16,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5547-4_10","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"assertion":[{"value":"23 September 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}